https://canceradvocacy.org/wp-content/uploads/2014/07/Fotolia_23428619_S-e1461260836640.jpg
515
1030
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-03-13 10:57:472018-03-13 10:57:47NCCS Joins Cancer Leadership Council to Oppose the Latest Version of Right to Try ActAccess to Care
Access to quality, affordable cancer care is essential for anyone with a cancer diagnosis. Access includes adequate health insurance that covers needed treatments without leaving people with cancer to suffer “financial toxicity.” People with cancer also need the ability to participate in a clinical trial, if it represents a potential treatment option.
Prior to the Affordable Care Act (ACA), cancer survivors were at the mercy of the health care system, often forced to pay exorbitant premiums or simply denied coverage altogether. Today, America’s 18.1 million cancer survivors benefit from the ACA’s patient protections that provide them with quality, affordable, and accessible health care coverage. Through the ACA, cancer patients and survivors can now purchase insurance through Healthcare.gov and state insurance exchanges. The ACA has afforded protections related to out-of-pocket expenses, lifetime caps, and pre-existing conditions.
NCCS believes in the following principles for access to care:
- Individuals with pre-existing conditions must not be denied coverage or charged higher premiums.
- Plans must cover all essential health care needs.
- Adequate financial assistance must be provided to ensure people with low and moderate incomes can purchase health insurance.
- Insurers must not discriminate against older Americans, who are disproportionately impacted by cancer, or women.
- Cost-sharing protections must be maintained, including caps on out-of-pocket costs and the elimination of annual and lifetime maximum benefits.
- States should take advantage of the ACA’s Medicaid expansion, which provides coverage to low income individuals living with cancer.
- People with pre-existing conditions must not be segregated into high-risk pools, which are expensive and burdensome and do not meet the needs of cancer patients.
- Cancer patients must have access to comprehensive and well-coordinated cancer care, including clinical trials.
“For a cancer survivor, dealing with the collateral damage of cancer treatment and the continued surveillance for recurrence or secondary cancers, going without insurance is simply not an option. I am very worried that the proposed replacement for the ACA will harm cancer survivors, particularly people with low incomes and people over the age of 50. We simply can’t go back to the days before the ACA when cancer survivors could be denied coverage, and we must ensure people have access to quality, affordable health insurance.”
Michael Kappel, NCCS board member and 13-year colon cancer survivor
https://canceradvocacy.org/wp-content/uploads/2014/07/Fotolia_23428619_S-e1461260836640.jpg
515
1030
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-03-13 10:57:472018-03-13 10:57:47NCCS Joins Cancer Leadership Council to Oppose the Latest Version of Right to Try Act
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png
250
250
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-03-09 17:40:262018-03-09 17:40:26WCOE: HHS Hints at Lax ACA Regulation; Burden of High Drug Costs; FDA’s Gottlieb Blasts ‘Rigged Payment Scheme’; Home BRCA Testing; More
https://canceradvocacy.org/wp-content/uploads/2017/01/ProtectOurCare-1024px.jpg
512
1024
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-03-09 16:13:182018-03-09 16:13:18ACA Update March 9, 2018 | HHS Says ‘Not Quite’ to Idaho’s Illegal Health Plans, Supports Expansion of Skinny Short-Term Coverage
https://canceradvocacy.org/wp-content/uploads/2014/07/Fotolia_23428619_S-e1461260836640.jpg
515
1030
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-03-08 13:08:082020-10-21 10:49:11Reps. DeSaulnier and Poe Introduce Bipartisan “Cancer Care Planning and Communications Act”
https://canceradvocacy.org/wp-content/uploads/2018/03/NCCS-Policy-Comments-DOL-Labor.jpg
600
1200
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-03-08 13:05:512018-03-08 13:05:51NCCS Letter to DOL: Proposed Association Health Plans Rule “Will Increase Costs for Cancer Survivors and Others with Significant Health Needs”
https://canceradvocacy.org/wp-content/uploads/2014/07/Fotolia_23428619_S-e1461260836640.jpg
515
1030
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-03-05 11:40:182018-03-05 11:40:18NCCS Joins Letter Expressing “Serious Reservations” About “Right to Try” Legislation
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png
250
250
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-03-02 17:26:372018-03-02 17:26:37What Caught Our Eye: NCI Chief Sharpless Interviewed; Expert Patients; “Why We Didn’t Seek Right to Try”; Progress in Survivorship Care; and More
https://canceradvocacy.org/wp-content/uploads/2018/02/10-Founders-1990-NCCS-Assembly.jpg
600
1200
actualize
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
actualize2018-02-28 12:21:582018-02-28 12:21:58Remembering Catherine Logan Carrillo, a Pioneer of the Survivorship Movement
